Consensus Eupraxia Pharmaceuticals Inc.

Equities

Delayed Toronto S.E. Other stock markets 14:48:14 2024-05-16 EDT			5-day change	1st Jan Change
4 ^CAD	0.00%		+1.27%	-25.51%

05-14	Eupraxia Pharmaceuticals Inc. Brief: Says To Present Initial Results from Ongoing Phase 1b Study of EP-104GI for Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024	MT
05-08	Eupraxia Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

faf64.xIA4vBYEa9iceu-o7hwpnpsU3JZR4hr3yp960n10A8g.telWiFN2LZPNNZvQ3kVu-c52stcfoEy58uYrsTIxdLiy8HnYLko7sfAprg~a57ac006f990271900e4f86c8dcd3dbe

22-06-09

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4 CAD

Average target price

14.45 CAD

Spread / Average Target

+261.25%

High Price Target

16.5 CAD

Spread / Highest target

+312.50%

Low Price Target

12.4 CAD

Spread / Lowest Target

+210.00%

Raymond James